Cargando…

Risk factors associated with development of coinfection in critically Ill patients with COVID-19

BACKGROUND: At outset of the coronavirus disease 2019 (COVID-19) pandemic, the significance of bacterial and fungal coinfections in individuals with COVID-19 was unknown. Initial reports indicated that the prevalence of coinfection in the general population was low, but there was uncertainty regardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsini, Erica M., Sacha, Gretchen L., Han, Xiaozhen, Wang, Xiaofeng, Duggal, Abhijit, Rajendram, Prabalini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Critical Care Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475158/ https://www.ncbi.nlm.nih.gov/pubmed/36102003 http://dx.doi.org/10.4266/acc.2022.00136

Ejemplares similares

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis
por: Rajendram, Prabalini, et al.
Publicado: (2021)

A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019
por: King, Alexander H., et al.
Publicado: (2021)

Single-Center Experience of Outcomes and Prescribing Patterns of IV Immunoglobulin Use in Critically Ill Patients
por: Torbic, Heather, et al.
Publicado: (2021)

System-Wide Strategies Were Associated With Improved Outcome in Critically Ill Patients With Coronavirus Disease 2019: Experience From a Large Health-Care Network
por: Zhang, Peng, et al.
Publicado: (2021)

Nonbronchoscopic Bronchoalveolar Lavage Improves Respiratory Culture Accuracy in Critically Ill Patients
por: Jeng, Margaret, et al.
Publicado: (2023)

Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications
por: Mucha, Simon R., et al.
Publicado: (2023)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
por: Elabbadi, Alexandre, et al.
Publicado: (2021)

Atrial fibrillation of new onset during acute illness: prevalence of, and risk factors for, persistence after hospital discharge
por: Ramanathan, Abarna, et al.
Publicado: (2021)

Critical Care Among Disadvantaged Minority Groups Made Equitable: Trends Throughout the COVID-19 Pandemic
por: Lopez, Diana Cristina, et al.
Publicado: (2022)

The Prevalence of Bacterial and Fungal Coinfections among Critically Ill COVID-19 Patients in the ICU in Jordan
por: Alsheikh, Ayman Daifallah, et al.
Publicado: (2022)

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Clinical characteristics and outcomes of critically Ill patients with COVID-19 in Northeast Ohio: low mortality and length of stay
por: Fadel, Francois Abi, et al.
Publicado: (2020)

COVID-19: Risk factors for critical illness
por: Gao, Yadong
Publicado: (2020)

Critical illness associated with 2013-2014 influenza A (H1N1): Postpandemic characteristics, presentation and outcomes
por: Wiesen, Jonathan, et al.
Publicado: (2015)

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
por: Sheng, Calvin C, et al.
Publicado: (2020)

Cytomegalovirus Coinfection in Critically Ill Patients with Novel Coronavirus-2019 Disease: Pathogens or Spectators?
por: Siddiqui, Suhail S, et al.
Publicado: (2022)

Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
por: Chen, Ziying, et al.
Publicado: (2023)

Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
por: Galli, Flavia, et al.
Publicado: (2023)

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
por: Cremer, Paul C, et al.
Publicado: (2021)

Year in review 2012: Critical Care -management
por: Duggal, Abhijit, et al.
Publicado: (2013)

Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients
por: Novy, Emmanuel, et al.
Publicado: (2021)

THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19
por: Trelles Garcia, Daniela, et al.
Publicado: (2020)

Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients
por: Silva, D.L., et al.
Publicado: (2021)

Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation
por: Cremer, Paul C, et al.
Publicado: (2021)

Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
por: Bauer, Seth R., et al.
Publicado: (2022)

Bacterial and Fungal Coinfection in Critically Ill COVID-19 Cases and Predictive Role of Procalcitonin During the First Wave at an Academic Health Center
por: Alnimr, Amani M., et al.
Publicado: (2022)

Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Moffitt, Kristin L, et al.
Publicado: (2023)

Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks
por: Duggal, Abhijit, et al.
Publicado: (2016)

DVT incidence and risk factors in critically ill patients with COVID-19
por: Chen, Shujing, et al.
Publicado: (2020)

Characteristics and risk factors associated with critical illness in pediatric COVID-19
por: Fisler, Grace, et al.
Publicado: (2020)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients
por: Haksteen, Wolmet E., et al.
Publicado: (2021)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Risk factors for death in chronic critical illness
por: Lokhandwala, S, et al.
Publicado: (2015)

Risk factors for agitation in critically ill patients
por: de Almeida, Thiago Miranda Lopes, et al.
Publicado: (2016)

Fungal, parasitological, and bacterial coinfection in a severely ill COVID‐19 patient in Peru
por: Moya‐Salazar, Jeel, et al.
Publicado: (2022)

Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia
por: Alqahtani, Abdulaziz, et al.
Publicado: (2022)

Impact of Non-viral Coinfections on Mortality of Severely Ill COVID-19 Patients in Dubai
por: Nadeem, Rashid, et al.
Publicado: (2022)

Leprosy reactions: coinfections as a possible risk factor
por: Motta, Ana Carolina F, et al.
Publicado: (2012)

Pneumococcal pneumonia coinfection in critically ill patients with influenza a (h1n1) primary viral pneumonia
por: González De Molina, FJ, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_42kub81gojfontb6k5avsdompf